NASDAQ: AMRN - Amarin

Yield per half year: -21.31%
Dividend yield: 0.00%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	Amarin	Gilead Sciences	Amgen
Capitalization
Price	0.459	107.89	306.86
Price priv.
Number of shares, million	410.94	1258	538
Capitalization, billion	0.4283	94.55	140.05
EBITDA, billion	-0.0742	7.61	7.9
EV, billion	0.069	119.11	206.55
Profit and loss report
Net profit, billion	-0.0822	5.67	6.72
Revenue, billion	0.2046	27.12	28.19
EPS	-0.2	4.5	12.49
Balance
Assets, billion	0.6853	62.13	97.15
Debt, billion	0.0077	24.99	64.61
Balance cost, billion	0.4862	22.75	6.23
Cash, billion	0.121	6.09	10.94
Coefficients
Dividend yield, %	0	3.69	2.92
Dividend	0	3.87	9.13
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	0	67.24	67.83
P/S	0.891	3.7	5.42
P/BV	0.3749	4.41	24.53
P/E	67	17.69	22.76
Ev/Ebitda	-0.9299	15.66	26.16
Debt/Ebitda	-0.1041	3.29	8.18
Efficiency
ROE	-15.83	24.9	107.78
ROA	-10.83	9.12	6.91
ROIC	-3.52	11.06	17
Ebitda margin	-36.26	28.05	28.01
Net margin	-40.17	20.89	23.83
Momentum
1 week, price changes	-0.2174 %	+0.3535 %	-2.82 %
1 month, price changes	-20.17 %	-2.83 %	-0.9234 %
3 months, price changes	+0.5036 %	+14.84 %	+16.02 %
6 months, price changes	-21.31 %	+29.93 %	-3.84 %
1 year, price changes	-48.38 %	+47.77 %	+7.18 %
3 years, price changes	-85.7 %	+81.82 %	+31.59 %
5 years, price changes	-90.48 %	+80.42 %	+33.46 %
10 years, price changes	-75.59 %	+24.66 %	+101.52 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe